Nanoengineered myogenic scaffolds for skeletal muscle tissue engineering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Extreme skeletal muscle loss leads to permanent disability and significant economic burden.
• Current surgical and tissue engineering strategies for muscle regeneration are inadequate.
• Existing methods fail to provide a suitable environment for cell infiltration, proliferation, and differentiation.

Purpose of the Study:

• To develop a nanoengineered scaffold for skeletal muscle regeneration.
• To optimize the scaffold for enhanced proliferation and differentiation of muscle progenitor cells.
• To control the release of insulin-like growth factor 1 (IGF-1) for improved myogenic potential.

Main Methods:

• Fabrication of a functionalized gelatin methacrylate (GelMA) hydrogel scaffold.
• Incorporation of LAPONITE® nanoclays (NCs) for controlled release of IGF-1.
• Assessment of IGF-1 release kinetics and its effect on cell proliferation and differentiation.

Main Results:

• The GelMA-NC scaffold demonstrated controlled release of IGF-1 over two weeks.
• NCs retained 50% of released IGF-1 within the hydrogel, enhancing cell proliferation and differentiation.
• The scaffold required 44% less IGF-1 compared to control hydrogels for similar efficacy.

Conclusions:

• The nanoengineered scaffold provides a viable option for treating severe muscle injuries.
• This approach offers scalable benefits for translational regenerative medicine.
• The technology has potential applications in clean meat production.